Patents by Inventor Christine E. Bulawa

Christine E. Bulawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aspergillus N-myristoyl transferase genes and polypeptides and uses thereof
    Publication number: 20020025524
    Abstract: Disclosed is an Aspergillus fumigatus N-myristoyltransferase gene and its use in identifying antifungal agents, for example.
    Type: Application
    Filed: May 15, 2001
    Publication date: February 28, 2002
    Applicant: Millennium Pharmaceuticals, Inc., a Delaware corporation
    Inventors: W. James Cook, Christine E. Bulawa
  • Methods for identifying inhibitors of fungal pathogenicity
    Patent number: 6251955
    Abstract: Methods of detecting inhibitors of fungal pathgenicity are disclosed. These methods are based on the discovery that pathogenicity is diminished when chitin synthase III is inhibited. The inhibitors of fungal pathogenicity are detected with mutant strains of S. cerevisiae or other mutant fungal strains, whose mutation causes diminished growth of the fungus when combined with the inhibition of chitin synthase III.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: June 26, 2001
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventor: Christine E. Bulawa
  • Aspergillus N-myristoyl transferase genes and polyeptides and uses thereof
    Patent number: 6251596
    Abstract: Disclosed is an Aspergillus fumigatus N-myristoyltransferase gene and its use in identifying antifungal agents, for example.
    Type: Grant
    Filed: September 30, 1998
    Date of Patent: June 26, 2001
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: W. James Cook, Christine E. Bulawa
  • Methods for identifying inhibitors of fungal pathogenicity
    Patent number: 5614377
    Abstract: Methods of detecting inhibitors of fungal pathogenicity are disclosed. These methods are based on the discovery that pathogenicity is diminished when chitin synthase III is inhibited. The inhibitors of fungal pathogenicity are detected with mutant strains of Saccharomyces cerevisiae or other mutant fungal strains, whose mutation causes diminished growth of the fungus when combined with the inhibition of chitin synthase III.
    Type: Grant
    Filed: February 28, 1994
    Date of Patent: March 25, 1997
    Assignee: Myco Pharmaceuticals, Incorporated
    Inventor: Christine E. Bulawa